Our host, Richard Sokolov, Executive Director and co-founder of IDE Group, speaks with Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals.
About the Episode
Richard and Alan discuss advice on capital raising, the importance of having skin in the game, why intellectual property is so important in life sciences, how Clarity went from two provisional patents to biggest IPO on the ASX, and many more topics.
About Dr Alan Taylor and Clarity Pharmaceuticals
Alan is an expert on capital raising with 15 years of investment banking experience. Before joining Clarity, he was an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank. Alan has significant experience in capital raisings and mergers&acquisitions and has been involved in approximately $2 billion worth of transactions.
He joined Clarity when there was only a single founder and two provisional patents in 2013 and has recently led the Company through the largest ever biotechnology IPO on the Australian Securities Exchange, raising $92 million at a capitalisation of $358 million. Since joining Clarity, Alan has led over $140 million of capital raisings for the company.
Clarity is focused on theranostics, a field that combines therapy and diagnostics. It is developing Targeted Copper Theranostic (TCT) products, which allow copper isotopes to be used in the diagnosis and treatment of a range of cancers, including prostate and breast cancers, as well as rare and orphan cancer indications such as neuroblastoma - a childhood cancer that begins most often in the nerve cells outside of brain of infants and children younger than 5 years old.
About the BBFH Series
The BBFH series is a series of interviews with Founders, Professors, Executives, and other leaders of the Australian startup community. Together with our guests, we explore and analyse the drivers and challenges of the healthcare startup community here in Australia and discuss their unique journeys and stories.
Chapters/Timestamps
0:00 Introduction
0:58 Clarity Pharmaceuticals’ story
3:06 Alan’s story at Clarity
5:38 Skin in the game as a leader
7:33 Why purpose is important
10:30 Alan’s story and why losing is important
20:25 Why Intellectual Property in Medtech/LifeSciences is important
24:45 Patent/IP lifespan and strategy
28:05 Enthusiasm and challenging each other
30:10 Advice on Capital Raising
34:00 Bringing your shareholders along
35:50 The Dark Side and trying to find the right people to hang out with
37:50 BBFH, sharing knowledge and the Australian startup community
40:34 Why startups are incredible hard
41:30 Progress during difficult times
44:55 How the adoption of science inspires future generations
Links
Website: https://www.idegroup.com.au/videos-podcasts
Website BBFH Challenge: https://www.bbfhchallenge.com/
LinkedIn: https://www.linkedin.com/company/ide-/
Twitter: https://twitter.com/ide_group
Facebook: https://www.facebook.com/IDEGroupAU/
Instagram: https://www.instagram.com/ide.group/
See omnystudio.com/listener for privacy information.
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Nikki Glaser Podcast
Every week comedian and infamous roaster Nikki Glaser provides a fun, fast-paced, and brutally honest look into current pop-culture and her own personal life.